Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2010, Article ID 148528, 6 pages
http://dx.doi.org/10.1155/2010/148528
Review Article

Microscopic Polyangiitis in Systemic Sclerosis

1Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyoku, Tokyo 113-0033, Japan
2Division of Rheumatology, Aiwakai Medical Corporation, 1-22-23 Kamiyouga, Setagayaku, Tokyo 158-0098, Japan

Received 14 May 2010; Accepted 12 July 2010

Academic Editor: Eswar Krishnan

Copyright © 2010 Hiroshi Hashimoto. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. A. Medsger, “Systemic sclerosis (scleroderma): clinical aspect,” in Arthritis and Allied Conditions, W. J. Koopman, Ed., pp. 1590–1624, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2001. View at Google Scholar
  2. J. C. Jennette, R. J. Falk, K. Andrassy et al., “Nomenclature of systemic vasculitides: proposal of an international consensus conference,” Arthritis and Rheumatism, vol. 37, no. 2, pp. 187–192, 1994. View at Google Scholar · View at Scopus
  3. G. S. Hoffman and U. Specks, “Antineutrophil cytoplasmic antibodies,” Arthritis and Rheumatism, vol. 41, no. 9, pp. 1521–1537, 1998. View at Google Scholar · View at Scopus
  4. L. Guillevin, B. Durand-Gasselin, R. Cevallos et al., “Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients,” Arthritis and Rheumatism, vol. 42, no. 3, pp. 421–430, 1999. View at Google Scholar · View at Scopus
  5. E. C. Hagen, M. R. Daha, J. Hermans et al., “Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis,” Kidney International, vol. 53, no. 3, pp. 747–753, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. R. A. Watts, D. G. I. Scott, D. R. W. Jayne et al., “Renal vasculitis in Japan and the UK—are there differences in epidemiology and clinical phenotype?” Nephrology Dialysis Transplantation, vol. 23, no. 12, pp. 3928–3931, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Chen, F. Yu, Y. Zhang, W.-Z. Zou, M.-H. Zhao, and H.-Y. Wang, “Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies,” Kidney International, vol. 68, no. 5, pp. 2225–2229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Yoshida, T. Iwahori, I. Nakabayashi, M. Akashi, T. Watanabe, and N. Yoshikawa, “In vitro production of myeloperoxidase anti-neutrophil cytoplasmic antibody and establishment ot Th1-type T cell lines from peripheral blood lymphocytes of patients,” Clinical and Experimental Rheumatology, vol. 23, no. 2, pp. 227–230, 2005. View at Google Scholar · View at Scopus
  9. S. Fujimoto, S. Uezono, S. Hisanaga et al., “Incidence of ANCA-associated primary renal vasculitis in the Miyazaki prefecture: the first population-based, retrospective, epidemiologic survey in Japan,” Clinical Journal of the American Society of Nephrology, vol. 1, no. 5, pp. 1016–1022, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Malenica, M. Rudolf, and A. Kozmar, “Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis,” Acta Dermatovenerologica Croatica, vol. 12, no. 4, pp. 294–313, 2004. View at Google Scholar · View at Scopus
  11. W. L. Gross, W. H. Schmitt, and C. E. DiplBiol, “Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective,” American Journal of Kidney Diseases, vol. 18, no. 2, pp. 175–179, 1991. View at Google Scholar · View at Scopus
  12. P. A. Merkel, R. P. Polisson, Y. Chang, S. J. Skates, and J. L. Niles, “Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease,” Annals of Internal Medicine, vol. 126, no. 11, pp. 866–873, 1997. View at Google Scholar · View at Scopus
  13. H. Endo, T. Hosono, and H. Kondo, “Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis,” Journal of Rheumatology, vol. 21, no. 5, pp. 864–870, 1994. View at Google Scholar · View at Scopus
  14. S. Akimoto, O. Ishikawa, T. Tamura, and Y. Miyachi, “Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis,” British Journal of Dermatology, vol. 134, no. 3, pp. 407–410, 1996. View at Google Scholar · View at Scopus
  15. A. Ruffatti, R. A. Sinico, A. Radice et al., “Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis,” Journal of Rheumatology, vol. 29, no. 5, pp. 918–923, 2002. View at Google Scholar · View at Scopus
  16. S. Kiraz, H. Simsek, I. Ertenli, M. Benekli, and A. Kadayifci, “Antineutrophil cytoplasmic antibodies in systemic sclerosis,” Clinical Rheumatology, vol. 15, no. 5, pp. 519–520, 1996. View at Google Scholar · View at Scopus
  17. S. Casari, M. Haeney, S. Ferrand, and A. Herrick, “Antineutrophil cytoplasmic antibodies—a “red flag” in patients with systemic sclerosis,” Journal of Rheumatology, vol. 29, no. 12, pp. 2666–2667, 2002. View at Google Scholar · View at Scopus
  18. D. Khanna, A. Aggarwal, D. S. Bhakuni, R. Dayal, and R. Misra, “Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis,” Journal of Rheumatology, vol. 30, no. 6, pp. 1248–1252, 2003. View at Google Scholar · View at Scopus
  19. H. Hashimoto, T. Yano, M. Yoshida, S. Kobayashi, K. Sueishi, N. Tsusaka et al., “Clinical and epidemiological analysis of anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitis from a nationwide survey in 1998 in Japan,” Annual Report of The Research Committee of Intractable Vasculitis Diseases, The Ministry of Health and Welfare of Japan, 1999. View at Google Scholar
  20. E. C. LeRoy, C. Black, R. Fleischmajer et al., “Scleroderma (systemic sclerosis): classification, subsets and pathogenesis,” Journal of Rheumatology, vol. 15, no. 2, pp. 202–205, 1988. View at Google Scholar · View at Scopus
  21. Y. H. Rho, S. J. Choi, Y. H. Lee, J. D. Ji, and G. G. Song, “Scleroderma associated with ANCA-associated vasculitis,” Rheumatology International, vol. 26, no. 5, pp. 465–468, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. W. A. D'Angelo, J. F. Fries, A. T. Masi., and L. E. Shulman, “Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls,” The American Journal of Medicine, vol. 46, no. 3, pp. 428–440, 1969. View at Google Scholar · View at Scopus
  23. D. J. Helfrich, B. Banner, V. D. Steen, and T. A. Medsger Jr., “Normotensive renal failure in systemic sclerosis,” Arthritis and Rheumatism, vol. 32, no. 9, pp. 1128–1134, 1989. View at Google Scholar · View at Scopus
  24. K. Joh, E. Muso, H. Shigematsu et al., “Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan,” Clinical and Experimental Nephrology, vol. 12, no. 4, pp. 277–291, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. G. P. Rodnan, G. E. Schreiner, and R. L. Black, “Renal involvement in progressive systemic sclerosis (generalized scleroderma),” The American Journal of Medicine, vol. 23, no. 3, pp. 445–462, 1957. View at Google Scholar · View at Scopus
  26. P. A. Bacon and D. Adu, “Microscopic polyangiitis: clinical aspects,” in Inflammatory Diseases of Blood Vessels, G. S. Hoffman and C. M. Weyand, Eds., pp. 355–363, Marcel Dekker, New York, NY, USA, 2002. View at Google Scholar
  27. D. Launay, R. Souza, L. Guillevin et al., “Pulmonary arterial hypertension in ANCA-associated vasculitis,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 23, no. 3, pp. 223–228, 2006. View at Google Scholar · View at Scopus
  28. N. P. Quillinan and C. P. Denton, “Disease-modifying treatment in systemic sclerosis: current status,” Current Opinion in Rheumatology, vol. 21, no. 6, pp. 636–641, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Harper, “Recent advances to achieve remission induction in antineutrophil cytoplasmic antibody-associated vasculitis,” Current Opinion in Rheumatology, vol. 22, no. 1, pp. 37–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. D. J. Schlieben, S. M. Korbet, R. E. Kimura, M. M. Schwartz, and E. J. Lewis, “Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs,” American Journal of Kidney Diseases, vol. 45, no. 4, pp. 758–761, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Cheung, G. Chew, R. Wyndham, M. Peters, and S. Riminton, “Myeloperoxidase-antineutrophil cytoplasmic antibody seroconversion and fulminant vasculitis in Scl-70-positive scleroderma,” Internal Medicine Journal, vol. 37, no. 3, pp. 205–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Brinkmann, U. Reichard, C. Goosmann et al., “Neutrophil extracellular traps kill bacteria,” Science, vol. 303, no. 5663, pp. 1532–1535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Kessenbrock, M. Krumbholz, U. Schönermarck et al., “Netting neutrophils in autoimmune small-vessel vasculitis,” Nature Medicine, vol. 15, no. 6, pp. 623–625, 2009. View at Publisher · View at Google Scholar · View at Scopus